Bangkok (NNT/VNA) - The Thailand Institute of Nuclear Technology(TINT) has signed a deal with Nagase Thailand to appoint the company as anofficial reseller of the radiopharmaceuticals product Technetium-99m inMyanmar.
TINT Executive Director Thawatchai Onjun has said that the institute hasappointed Nagase Thailand an official reseller of a therapeuticradiopharmaceuticals Technetium-99m in Myanmar, marking the first attempt byThailand to make a commercial sale of radiopharmaceuticals made in Thailand ina foreign country.
Technetium-99m is a radiopharmaceuticals product commonly used at hospitals inphysical examinations. TINT expects the two-year contract for sales in Myanmarwill help initiate sales to other countries, especially in the ASEAN region,helping stress the institute’s position as the region’s leader in nucleartechnology.
Nagase Thailand’s Managing Director, Kenichi Kurimoto said the company hopes toextend the business beyond Myanmar to other countries, such as Malaysia, aswell as ASEAN countries where the company has local offices, in both Laos andCambodia.
ASEAN countries have previously relied on the importation of radiopharmaceuticalsfrom Japan, South Korea, and European countries, with only limited localmanufacturing and sales within the region. TINT is positive made-in-Thailandradiopharmaceuticals will be internationally accepted for their quality./.
TINT Executive Director Thawatchai Onjun has said that the institute hasappointed Nagase Thailand an official reseller of a therapeuticradiopharmaceuticals Technetium-99m in Myanmar, marking the first attempt byThailand to make a commercial sale of radiopharmaceuticals made in Thailand ina foreign country.
Technetium-99m is a radiopharmaceuticals product commonly used at hospitals inphysical examinations. TINT expects the two-year contract for sales in Myanmarwill help initiate sales to other countries, especially in the ASEAN region,helping stress the institute’s position as the region’s leader in nucleartechnology.
Nagase Thailand’s Managing Director, Kenichi Kurimoto said the company hopes toextend the business beyond Myanmar to other countries, such as Malaysia, aswell as ASEAN countries where the company has local offices, in both Laos andCambodia.
ASEAN countries have previously relied on the importation of radiopharmaceuticalsfrom Japan, South Korea, and European countries, with only limited localmanufacturing and sales within the region. TINT is positive made-in-Thailandradiopharmaceuticals will be internationally accepted for their quality./.
VNA
